Australian API Manufacturer Draws FDA Warning Over Quality Investigations

Drug Industry Daily
A A
The FDA warned API and finished drug manufacturer IDT Australia for failure to investigate quality issues and for incomplete records.

To View This Article:

Login

Subscribe To Drug Industry Daily